BioLargo Inc (BLGO)

Currency in USD
0.1752
-0.0125(-6.66%)
Closed·
BLGO is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.17510.1940
52 wk Range
0.14010.3200
Key Statistics
Prev. Close
0.1877
Open
0.1877
Day's Range
0.1751-0.194
52 wk Range
0.1401-0.32
Volume
688.05K
Average Volume (3m)
525.17K
1-Year Change
-2.23%
Book Value / Share
0.02
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BLGO Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
0.3200
Upside
+82.65%
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week

BioLargo Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Neutral

BioLargo Inc Company Profile

BioLargo, Inc. invents, develops, and commercializes various platform technologies. The company’s technologies solve challenging environmental problems comprising per - and polyfluoroalkyl substances (PFAS) water contamination, advanced water and wastewater treatment, industrial odor and volatile organic compounds control, air quality control, infection control, and myriad environmental remediation. It provides full-service environmental engineering services. BioLargo, Inc. is based in Westminster, California.

Industry
Chemicals
Employees
42

BioLargo Inc Earnings Call Summary for Q3/2025

  • BioLargo reported a 50% year-over-year revenue decline in Q3 2025, with a $3.85 million credit loss from a Poof dispute, causing shares to fall 7.87% to $0.1699
  • The company maintains a $4.5 million cash position and over $9 million in total assets, despite missing EPS forecasts of -$0.01 and revenue projections of $4.1 million
  • CEO Dennis Calvert remains optimistic about BioLargo's innovation pipeline, noting the company is '95% awesome, 5% pretty much kicking our butt'
  • Strategic focus includes upcoming Clyra Medical products launch, sodium-based battery technology advancement, and PFAS solutions with potential valuation of $60-750 million
  • Management seeks strategic investments and partnerships to support growth initiatives in emerging markets like PFAS remediation and long-duration energy storage
Last Updated: 15/11/2025, 00:04
Read Full Transcript

Compare BLGO to Peers and Sector

Metrics to compare
BLGO
Peers
Sector
Relationship
P/E Ratio
−5.6x−6.6x0.2x
PEG Ratio
0.02−0.060.00
Price/Book
8.4x2.0x1.6x
Price / LTM Sales
5.1x2.8x1.3x
Upside (Analyst Target)
82.6%15.6%24.2%
Fair Value Upside
Unlock3.3%−0.2%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 0.3200
(+82.65% Upside)

Earnings

Latest Release
Nov 17, 2025
EPS / Forecast
-0.02 / -0.01
Revenue / Forecast
1.10M / 4.10M
EPS Revisions
Last 90 days

BLGO Income Statement

People Also Watch

44.21
EXEL
+2.50%
1.540
SLNH
-1.91%
6.290
GSIT
+4.83%
19.1400
ADMA
-0.36%
5.39
GAMB
+5.07%

FAQ

What Stock Exchange Does BioLargo Trade On?

BioLargo is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for BioLargo?

The stock symbol for BioLargo is "BLGO."

What Is the BioLargo (BLGO) Afterhours Price Today? (Afterhours variable test: 0.2250) Current Date: 28 Nov 2025

After hours price: 0.2250. After hours price change (units): 0.0002. Price change percentage: 0.0900%

What Is the BioLargo Market Cap?

As of today, BioLargo market cap is 54.97M.

What Is BioLargo's Earnings Per Share (TTM)?

The BioLargo EPS (TTM) is -0.03.

When Is the Next BioLargo Earnings Date?

BioLargo will release its next earnings report on 05 Apr 2026.

From a Technical Analysis Perspective, Is BLGO a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has BioLargo Stock Split?

BioLargo has split 1 times.

How Many Employees Does BioLargo Have?

BioLargo has 42 employees.

What is the current trading status of BioLargo (BLGO)?

As of 28 Nov 2025, BioLargo (BLGO) is trading at a price of 0.1752, with a previous close of 0.1877. The stock has fluctuated within a day range of 0.1751 to 0.1940, while its 52-week range spans from 0.1401 to 0.3200.

What Is BioLargo (BLGO) Price Target According to Analysts?

The average 12-month price target for BioLargo is USD0.32, with a high estimate of USD0.32 and a low estimate of USD0.32. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +82.65% Upside potential.

What Is the BLGO After Hours Price?

BLGO's last after hours stock price is 0.2250, the stock has decreased by 0.0002, or 0.0900%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.